NeueHealth Management
Management criteria checks 3/4
NeueHealth's CEO is Mike Mikan, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is $9.90M, comprised of 13.1% salary and 86.9% bonuses, including company stock and options. directly owns 1.01% of the company’s shares, worth $317.17K. The average tenure of the management team and the board of directors is 2.2 years and 5.4 years respectively.
Key information
Mike Mikan
Chief executive officer
US$9.9m
Total compensation
| CEO salary percentage | 13.1% |
| CEO tenure | 5.9yrs |
| CEO ownership | 1.0% |
| Management average tenure | 2.2yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Bright Health Group: Stock Price Has Been Too Heavily Beaten Down
Jan 19Bright Health Group expects FY23 revenue to be below consensus
Jan 10Bright Health receives non-compliance notice from NYSE
Dec 12Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance
Nov 09Bright Health narrows footprint to only offer Medicare Advantage in California, Florida
Oct 11Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report
Aug 13
Bright Health Group Takes Cost Actions To Effect Turnaround
Jul 21Bright Health Group: Examining A Dumpster Fire
Jan 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$28m |
| Jun 30 2024 | n/a | n/a | -US$495m |
| Mar 31 2024 | n/a | n/a | -US$510m |
| Dec 31 2023 | US$10m | US$1m | -US$563m |
| Sep 30 2023 | n/a | n/a | -US$825m |
| Jun 30 2023 | n/a | n/a | -US$407m |
| Mar 31 2023 | n/a | n/a | -US$447m |
| Dec 31 2022 | US$10m | US$1m | -US$521m |
| Sep 30 2022 | n/a | n/a | -US$373m |
| Jun 30 2022 | n/a | n/a | -US$513m |
| Mar 31 2022 | n/a | n/a | -US$450m |
| Dec 31 2021 | US$181m | US$1m | -US$330m |
| Sep 30 2021 | n/a | n/a | -US$534m |
| Jun 30 2021 | n/a | n/a | -US$293m |
| Mar 31 2021 | n/a | n/a | -US$266m |
| Dec 31 2020 | US$5m | US$600k | -US$161m |
Compensation vs Market: Mike's total compensation ($USD9.90M) is above average for companies of similar size in the US market ($USD653.16K).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
CEO
Mike Mikan (52 yo)
5.9yrs
Tenure
US$9,898,059
Compensation
Mr. George Lawrence Mikan, III, also known as Mike, is Chief Executive Officer at NeueHealth, Inc. (formerly known as Bright Health Group, Inc.) (formerly Bright Health, Inc) since April 2020 and its Presi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 9.9yrs | no data | 3.1% $ 975.8k | |
| Vice Chairman | 5.9yrs | US$9.90m | 1.01% $ 317.2k | |
| Chief Financial Officer | 1.6yrs | US$1.77m | 0.11% $ 36.2k | |
| Executive Vice President of Consumer Care | 1.1yrs | US$1.59m | 0.062% $ 19.5k | |
| Chief Accounting Officer | no data | no data | 0.044% $ 14.0k | |
| General Counsel & Corporate Secretary | 2.8yrs | US$832.55k | 0.042% $ 13.1k | |
| Chief People Officer | no data | no data | no data | |
| President of Value-Based Care | no data | no data | no data |
2.2yrs
Average Tenure
49yo
Average Age
Experienced Management: NEUE's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 9.9yrs | no data | 3.1% $ 975.8k | |
| Vice Chairman | 5.9yrs | US$9.90m | 1.01% $ 317.2k | |
| Independent Director | 3.3yrs | US$153.68k | 0.17% $ 52.2k | |
| Independent Director | 4.7yrs | US$173.68k | 0.16% $ 51.3k | |
| Independent Director | 8.8yrs | US$163.68k | 0.072% $ 22.7k | |
| Independent Director | 5.9yrs | US$163.68k | 1.21% $ 381.5k | |
| Independent Lead Director | 4.1yrs | US$188.68k | 0.28% $ 87.9k | |
| Independent Director | 8.8yrs | US$163.68k | 0.072% $ 22.7k | |
| Independent Director | 2.8yrs | US$153.68k | 0.076% $ 23.8k | |
| Independent Director | 4.8yrs | US$178.68k | 1.21% $ 381.5k |
5.4yrs
Average Tenure
62yo
Average Age
Experienced Board: NEUE's board of directors are considered experienced (5.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:13 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeueHealth, Inc. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Kevin Fischbeck | BofA Global Research |